These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 9531513)
1. Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. Postlind H; DanielsonA ; Lindgren A; Andersson SH Drug Metab Dispos; 1998 Apr; 26(4):289-93. PubMed ID: 9531513 [TBL] [Abstract][Full Text] [Related]
2. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes. Ekström G; Gunnarsson UB Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604 [TBL] [Abstract][Full Text] [Related]
3. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs. Andersson SH; Lindgren A; Postlind H Drug Metab Dispos; 1998 Jun; 26(6):528-35. PubMed ID: 9616187 [TBL] [Abstract][Full Text] [Related]
4. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes. Zhu M; Zhao W; Jimenez H; Zhang D; Yeola S; Dai R; Vachharajani N; Mitroka J Drug Metab Dispos; 2005 Apr; 33(4):500-7. PubMed ID: 15640381 [TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites. Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765 [TBL] [Abstract][Full Text] [Related]
7. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Miyazawa M; Shindo M; Shimada T Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812 [TBL] [Abstract][Full Text] [Related]
8. Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine. Brynne N; Dalén P; Alván G; Bertilsson L; Gabrielsson J Clin Pharmacol Ther; 1998 May; 63(5):529-39. PubMed ID: 9630826 [TBL] [Abstract][Full Text] [Related]
9. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver. Jönsson G; Aström A; Andersson P Drug Metab Dispos; 1995 Jan; 23(1):137-42. PubMed ID: 7720517 [TBL] [Abstract][Full Text] [Related]
10. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor. Zhang Y; Guo X; Lin ET; Benet LZ Drug Metab Dispos; 1998 Apr; 26(4):360-6. PubMed ID: 9531525 [TBL] [Abstract][Full Text] [Related]
11. Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe. Chauret N; Tremblay N; Lackman RL; Gauthier JY; Silva JM; Marois J; Yergey JA; Nicoll-Griffith DA Anal Biochem; 1999 Dec; 276(2):215-26. PubMed ID: 10603245 [TBL] [Abstract][Full Text] [Related]
12. Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A. von Moltke LL; Greenblatt DJ; Grassi JM; Granda BW; Venkatakrishnan K; Schmider J; Harmatz JS; Shader RI J Pharm Pharmacol; 1998 Sep; 50(9):997-1004. PubMed ID: 9811160 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of phencyclidine by human liver microsomes. Laurenzana EM; Owens SM Drug Metab Dispos; 1997 May; 25(5):557-63. PubMed ID: 9152594 [TBL] [Abstract][Full Text] [Related]
14. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037 [TBL] [Abstract][Full Text] [Related]
15. Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation of p-nitrophenol, a catalytic activity known to be specific for P450 2E1. Zerilli A; Ratanasavanh D; Lucas D; Goasduff T; Dréano Y; Menard C; Picart D; Berthou F Chem Res Toxicol; 1997 Oct; 10(10):1205-12. PubMed ID: 9348445 [TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease. Coleman T; Ellis SW; Martin IJ; Lennard MS; Tucker GT J Pharmacol Exp Ther; 1996 May; 277(2):685-90. PubMed ID: 8627546 [TBL] [Abstract][Full Text] [Related]
17. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone. Mäenpää J; Hall SD; Ring BJ; Strom SC; Wrighton SA Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752 [TBL] [Abstract][Full Text] [Related]
18. The interactions of a selective protein kinase C beta inhibitor with the human cytochromes P450. Ring BJ; Gillespie JS; Binkley SN; Campanale KM; Wrighton SA Drug Metab Dispos; 2002 Sep; 30(9):957-61. PubMed ID: 12167559 [TBL] [Abstract][Full Text] [Related]
19. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy. Martínez C; García-Martín E; Pizarro RM; García-Gamito FJ; Agúndez JA Br J Cancer; 2002 Sep; 87(6):681-6. PubMed ID: 12237780 [TBL] [Abstract][Full Text] [Related]
20. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Komatsu T; Yamazaki H; Asahi S; Gillam EM; Guengerich FP; Nakajima M; Yokoi T Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]